Case 1: "A 41-year-old woman from Puerto Rico with progressively worsening cough, associated with pleuritic chest pain and hemoptysis"

Presenter: Sarita Warrier, M.D., General Internal Medicine

On Panel: Muhanned Abu-Hijleh, M.D., Pulmonary; Jerome Larkin, M.D., Infectious Diseases; Eric Winer, M.D., Oncology; Bassam Aswad, M.D., Pathology

Objectives: At the conclusion of this conference, participants should be able to discuss the appropriate work-up and differential diagnosis of a patient presenting with hemoptysis.

Case 2: "A 71-year-old lady on peritoneal dialysis with hypokalemia and wrist pain"

Presenter: Dominick Tammaro, M.D., General Internal Medicine

On Panel: Douglas Shemin, M.D., Nephrology

Objectives: At the conclusion of this conference, participants should be able to identify benefits and complications of peritoneal dialysis and manifestations and treatment of potassium disorders in patients with end stage renal disease.

"Nephrology in China: Experience from the Nanjing Research Institute of Nephrology"

Zhi-Hong Liu, M.D., Director, Research Institute of Nephrology, Jinling Hospital, Professor of Medicine, Nanjing University School of Medicine, P R China

Objectives: At the conclusion of this conference, participants should be able to describe Nephrology in China, and the status quo of renal patient care, nephrology research and training program in the Research Institute of Nephrology at Nanjing University; and describe the productive relationship of sister renal center program between Nanjing and Brown.

"Multi-target immuno-therapy of severe lupus nephritis"

Lei-Shi Li, M.D., Vice Dean, Professor of Medicine, Department of Nephrology, Nanjing University School of Medicine, P R China

Objectives: At the conclusion of this conference, participants should be able to discuss a novel treatment of severe Lupus Nephritis with multi-target therapy (steroid + MMF + FK506), which will provide physicians with an opportunity to select an optimized immunosuppressive treatment for patients whose disease is refractory to the conventional therapy.

November 18, 2008: "Update on SLE"

Michelle Petri, M.D., MPH, Professor, Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine and Johns Hopkins Hospital, Baltimore, Maryland

Objectives: At the conclusion of this conference, participants should be able to: discuss the new epidemiologic and genetic data on SLE; describe studies of new immunosuppressives and biologics in lupus, especially lupus nephritis; and evaluate the role of traditional cardiovascular risk factor in accelerated atherosclerosis in lupus.

November 25, 2008: Nephrology Update - Updates in Kidney Transplantation

"Kidney Transplantation as a Treatment Option for End Stage Renal Disease"

Reginald Y. Gohh, M.D., Medical Director, Division of Organ Transplantation, Rhode Island Hospital, Associate Professor of Medicine, The Warren Alpert Medical School of Brown University

Objectives: At the conclusion of this conference, participants should be able to describe the efficacy of kidney transplantation as a treatment option for ESRD.

"Update in Immunosuppression for Kidney Transplantation"

Angelito F. Yango, Jr., M.D., Associate Director, Division of Organ Transplantation, Rhode Island Hospital, Assistant Professor of Medicine, The Warren Alpert Medical School of Brown University

Objectives: At the conclusion of this conference, participants should be able to discuss the immunosuppressive medications and protocols used in kidney transplantation.

"Ethical Issues in Living Donor Kidney Transplantation"

Terri L. Montague, M.D., Staff Nephrologist, Division of Kidney Disease and Hypertension, Rhode Island Hospital, Assistant Professor of Medicine (expected), The Warren Alpert Medical School of Brown University

Objectives: At the conclusion of this conference, participants should be able to discuss ethical concerns in living donor transplantation with particular focus on altruistic living donation; and identify donor options available for kidney transplantation.

• The Rhode Island Hospital fully intends to comply with the legal requirements of the Americans with Disabilities Act. If any participant of this conference is in need of accommodation, please contact the Rhode Island Hospital CME office at (401) 444-4260.

• The Department of Medicine Grand Rounds series is supported by an unrestricted educational fund as contributed by: Abbott Laboratories, Hoechst Marion Roussel, Merck & Co., The Liposome Company, Parke-Davis, Schering, Pfizer, Wyeth-Ayerst Laboratories, Eli Lilly and Company.

• Rhode Island Hospital is accreditied by the Rhode Island Medical Society to sponsor continuing medical education for physicians. Rhode Island Hospital designates this educational activity for 1 credit hour in Category 1 of the Physician's Recognition Award of the American Medical Association. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.